Literature DB >> 14729333

Heparin binds to the laminin alpha4 chain LG4 domain at a site different from that found for other laminins.

Hironobu Yamashita1, Konrad Beck, Yasuo Kitagawa.   

Abstract

We previously reported that the LG4 domain of the laminin alpha4 chain is responsible for high-affinity heparin binding. To specify the amino acid residues involved in this activity, we produced a series of alpha4 LG4-fusion proteins in which each of the 27 basic residues (arginine, R; histidine; lysine, K) were replaced one by one with alanine (A). When the effective residues R1520A, K1531A, K1533A, and K1539A are mapped on a structural model, they form a track on the concave surface of the beta-sandwich, suggesting that they interact with adjacent sulfate groups along the heparin chain. Whereas low-affinity heparin-binding sites of other LG domains have been located at the top of the beta-sheet sandwich opposite the N and C termini, the residues for high-affinity heparin binding of alpha4 LG4 reveal a new topological area of the LG module.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729333     DOI: 10.1016/j.jmb.2003.11.047

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

Review 1.  Amyloid accomplices and enforcers.

Authors:  Andrei T Alexandrescu
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

2.  Structural model of the amino propeptide of collagen XI alpha1 chain with similarity to the LNS domains.

Authors:  Arzhang Fallahi; Becky Kroll; Lisa R Warner; Rex J Oxford; Katey M Irwin; Linda M Mercer; Susan E Shadle; Julia Thom Oxford
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

3.  Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein.

Authors:  Daniel R Sandoval; Alejandro Gomez Toledo; Chelsea D Painter; Ember M Tota; M Osman Sheikh; Alan M V West; Martin M Frank; Lance Wells; Ding Xu; Roy Bicknell; Kevin D Corbett; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2020-01-21       Impact factor: 5.157

4.  Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.

Authors:  Qiong-Ying Hu; Elizabeth Fink; Meaghan Happer; John H Elder
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

5.  Cell surface proteoglycans syndecan-1 and -4 bind overlapping but distinct sites in laminin α3 LG45 protein domain.

Authors:  Sonia Carulli; Konrad Beck; Guila Dayan; Sophie Boulesteix; Hugues Lortat-Jacob; Patricia Rousselle
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

6.  Mammalian and Drosophila cells adhere to the laminin alpha4 LG4 domain through syndecans, but not glypicans.

Authors:  Hironobu Yamashita; Akira Goto; Tatsuhiko Kadowaki; Yasuo Kitagawa
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

7.  The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF.

Authors:  Sean M Anderson; Tom T Chen; M Luisa Iruela-Arispe; Tatiana Segura
Journal:  Biomaterials       Date:  2009-06-21       Impact factor: 12.479

8.  Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor.

Authors:  Christine K Abrass; Kim M Hansen; Bruce L Patton
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

9.  Capture of endothelial cells under flow using immobilized vascular endothelial growth factor.

Authors:  Randall J Smith; Maxwell T Koobatian; Aref Shahini; Daniel D Swartz; Stelios T Andreadis
Journal:  Biomaterials       Date:  2015-02-21       Impact factor: 12.479

Review 10.  Laminins in basement membrane assembly.

Authors:  Erhard Hohenester; Peter D Yurchenco
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.